Pear Therapeutics logo

Pear Therapeutics Funding & Investors

Pear Therapeutics is a provider of a software-based digital therapeutics platform designed to treat disease and enhance the efficacy of pharmaceuticals. The company's platform combines novel digital interventions with drugs to enhance efficacy well beyond anything that is commercially available or in clinical development, enabling clients to get better outcomes for patients, smarter engagement and tracking tools for clinicians, and cost-effective services for payors.

peartherapeutics.com

Total Amount Raised: $409,000,000

Pear Therapeutics Funding Rounds

  • Post Ipo Equity

    $125,000,000

    Post Ipo Equity Investors

    Neuberger Berman
    SoftBank Investment Advisers
    5am Ventures
    Sarissa Capital Management
    The Eleven Fund
    QUAD Investment Management
    Arboretum Ventures
    Pritzker Vlock Family Office
    Health Innovation Capital
    Shanda
    dRx Capital
    JAZZ Venture Partners
    Forth Management
    Blue Water Life Science Fund
    Temasek
    Pilot House Ventures
    Palantir Capital
    Trustbridge Partners
  • Series D

    $20,000,000

  • Series D

    $80,000,000

    Series D Investors

    SoftBank Investment Advisers
    EDBI
    5am Ventures
    Sarissa Capital Management
    QUAD Investment Management
    Arboretum Ventures
    Novartis
    Crimsonox Capital
    Shanda
    JAZZ Venture Partners
    Forth Management
    Temasek
    Pilot House Ventures
  • Debt Financing

    $50,000,000

    Debt Financing Investors

    Perceptive Advisors
  • Series C

    $64,000,000

    Series C Investors

    Arboretum Ventures
    Novartis
    Bridge Builders Collaborative
    EDBI
    JAZZ Venture Partners
    5am Ventures
    Blue Water Life Science Fund
    Temasek
    Trustbridge Partners
  • Series B

    $50,000,000

    Series B Investors

    Novartis
    Arboretum Ventures
    Bridge Builders Collaborative
    dRx Capital
    EDBI
    JAZZ Venture Partners
    5am Ventures
    Temasek
  • Series A

    $20,000,000

    Series A Investors

    Arboretum Ventures
    Novartis
    Bridge Builders Collaborative
    JAZZ Venture Partners
    5am Ventures
Funding info provided by Diffbot.